Transaction · 0000950170-25-032365

BURNETT JOSEPH MICHAEL

BURNETT JOSEPH MICHAEL, CEO, PRES, reported a transaction classified as grant at ClearPoint Neuro, Inc. involving 132841.000000 shares for an estimated $0.00. Reported holdings after the transaction were 132841.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

grantSEC transaction code ACEO, PRES
CLPTClearPoint Neuro, Inc.
Filing timeMar 04
Trade dateMar 03, 2025
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
—
Pre-filing
1mo ago1w ago1d ago
Returns since
7d30d90d180d1y

CLPT price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
CLPT since 2025-03-04Filed 549 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
grant
Code A
Identifier
0000950170-25-032365
Restricted Stock Units
Transaction date
Mar 03, 2025
Filed Mar 04, 2025, 10:00 PM · 1d delay
Shares
132k sh
$0 per share
Estimated value
$0
Computed from shares × price
Holdings after
132k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Derivative Transaction Direct Ownership Large Holdings Increase
-6score
Filing-only score

-6

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

CEO and President

Officer YesDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    Each restricted stock unit represents a contingent right to receive one share of CLPT common stock.

  2. F2

    The restricted stock units vest as follows: (i) 20% of the total shares on March 3, 2026; (ii) 40% of the total shares on March 3, 2027; and (iii) 40% of the total shares on March 3, 2028.

Original filing · 0000950170-25-032365
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

CLPT